Abstract
Subdermal contraceptive implants offer women long-acting, controlled release of progestins. Over the past 20 years, they have been approved in more than 60 countries and used by more than 11 million women worldwide. Their high efficacy along with ease of use make them a good contraceptive option for women who require progestin-only methods because they should not use estrogen, teens who find adherence to a contraceptive regime difficult, as well as healthy adult women who desire long-term protection (1). NorplantĀ®, no longer marketed in the United States, garnered 1 million American users but was difficult to insert and remove (2, 3). Now, a highly effective and long-lasting singlerod etonogestrel subdermal implant (ImplanonĀ®) will make implant contraception available again in the United States.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Darney PD, Atkinson E, Tanner S, MacPherson S, Hellerstein S, Alvarado A. (1990) Acceptance and perceptions of Norplant among users in San Francisco, USA. Stud Fam Plann 21:152ā160.
Bromham DR, Davey A, Gaffikin L, Ajello CA. (1995) Materials, methods and results of the Norplant training program. Adv Contracept 11:255ā262.
Dunson TR, Amatya RN, Krueger SL. (1995) Complications and risk factors associated with the removal of Norplant implants. Obstet Gynecol 85:543ā548.
Fu H, Darroch JE, Haas T, Ranjit N. (1999) Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 31:56ā63.
Meirik O, Farley TM, Sivin I, for the International Collaborative Post-Marketing Surveillance of Norplant. (2001) Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization. Obstet Gynecol 97:539ā547.
Diaz S, Herreros C, Juez G, et al. (1985) Fertility regulation in nursing women: influence of Norplant levonorgestrel implants upon lactation and infant growth. Contraception 32:53ā74.
Sivin I, Mishell DR Jr, Diaz S, et al. (2000) Prolonged effectiveness of NorplantĀ® capsule implants: a 7-year study. Contraception 61:187ā194.
Diaz S, Pavez M, Cardenas H, Croxatto HB. (1987) Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or copper-T IUDs. Contraception 35:569ā579.
Kuiper H, Miller S, Martinez E, Loeb L, Darney PD. (1997) The double paradox: urban adolescent females and the decline of contraceptive implants. Fam Plann Perspect 29:167ā172.
Brache V, Faundes A, Johansson E, Alvarez F. (1985) Anovulation, inadequate luteal phase, and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. Contraception 31:261ā273.
Croxatto HB, MƤkƤrƤinen L. (1998) The pharmacodynamics and efficacy of Implanon. Contraception 58:91Sā97S.
Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. (1999) Amulticentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod 14:976ā981.
Makarainen L, van Beek A, Tuomiyaara L, Asplund B, Bennink HC. (1998) Ovarian function during the use of a single contraceptive implant (Implanon) compared with Norplant. Fertil Steril 69:714ā721.
Mascarenhas L, van Beek A, Bennink H, Newton J. (1998) Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom. Contraception 58:215ā219.
Biswas A, Viegas OA, Bennink HJ, Korver T, Ratnam SS. (2000) Effect of Implanon use on selected parameters of thyroid and adrenal function. Contraception 62:247ā251.
Biswas A, Viegas OA, Coeling Bennink JH, Korver T, Ratnam SS. (2001) Implanon contraceptive implants: effects on carbohydrate metabolism. Contraception 63:137ā141.
Biswas A, Viegas OA, Roy AC. (2003) Effect of Implanon and Norplant subdermal contraceptive implants on serum lipidsāa randomized comparative study. Contraception 68:189ā193.
Meckstroth K, Darney PD. (2000) Implantable contraception. Obstet Gynecol Clin North Am 27:781ā815.
Meirik O, dāArcangues C, for the WHO Consultation on Implantable Contraceptives for Women. (2003) Implantable contraceptives for women. Hum Reprod Update 9:49ā59.
Affandi B, Korver T, Geurts TB, Coelingh Bennink JH. (1999) A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for< or = 4 years. Contraception 59:167ā174.
Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. (2000) Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device. Contraception 62:239ā246.
Mascarenhas L. (2000) Insertion and removal of Implanon: practical considerations. Eur J Contracept Reprod Health Care 5:29ā34.
Zieman M, Klaisle C, Walker D, Bahisteri E, Darney P. (1997) Fingers versus instruments for removing levonorgestrel contraceptive implants (Norplant). J Gynecol Tech 3:213ā217.
Smith A, Reuter S. (2002) An assessment of the use of Implanon in three community services. J Fam Plann Reprod Health Care 28:193ā196.
Shaaban MM, Salem HT, Abdullah KA. (1985) Influence of levonorgestrel contraceptive implants, Norplant, initiated early postpartum, upon lactation and infant growth. Contraception 32:623ā635.
Trussell J, Leveque JA, Koenig JD, et al. (1995) The economic value of contraception: a comparison of 15 methods. Am J Public Health 85:494ā503.
Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. (1996) Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 174:919ā922.
Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. (1999) A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (ImplanonĀ®) and a sixcapsule (NorplantĀ®) hormonal contraceptive implant. Contraception 60:1ā8.
Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C. (1996) Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users. Contraception 53:97ā100.
Sivin I, Mishell DR Jr, Darney P, Wan L, Christ M. (1998) Levonorgestrel capsule implants in the United States: a 5-year study. Obstet Gynecol 92:337ā344.
Darney PD, Callegari LS, Swift A, Atkinson ES, Robert AM. (1999) Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception. Am J Obstet Gynecol 180:929ā937.
Harrison-Woolrych M, Hill R. (2005) Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 71:306ā308.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Darney, P.D. (2006). Contraceptive Implants. In: Shoupe, D., Kjos, S.L. (eds) The Handbook of Contraception. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-150-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-150-5_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-599-6
Online ISBN: 978-1-59745-150-5
eBook Packages: MedicineMedicine (R0)